Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Daiichi and Sumitomo to copromote antiallergic drug in Japan

Jan. 19, 1998

Inhibitors of iNOS developed at Astra

Jan. 16, 1998

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Schering-Plough discovers dual NK1/NK2 antagonists from fungal strain

Jan. 15, 1998

Antiallergic efficacy of dual-action compound demonstrated in preclinical models

Jan. 14, 1998

New tachykinin antagonists from Schering-Plough

Jan. 8, 1998

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

Jan. 7, 1998

Effects of TxA2 antagonists on IL-8-induced bronchial hyperresponsiveness

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...